Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Urinary calcium response to high dose vitamin D3 with calcium supplementation in patients with multiple sclerosis.

Kimball SM, Burton JM, O'Connor PG, Vieth R.

Clin Biochem. 2011 Jul;44(10-11):930-2. doi: 10.1016/j.clinbiochem.2011.04.017. Epub 2011 May 5.

PMID:
21570386
2.

Safety of vitamin D3 in adults with multiple sclerosis.

Kimball SM, Ursell MR, O'Connor P, Vieth R.

Am J Clin Nutr. 2007 Sep;86(3):645-51.

3.

Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level.

Vieth R, Chan PC, MacFarlane GD.

Am J Clin Nutr. 2001 Feb;73(2):288-94.

4.

High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency.

von Restorff C, Bischoff-Ferrari HA, Theiler R.

Bone. 2009 Oct;45(4):747-9. doi: 10.1016/j.bone.2009.06.012. Epub 2009 Jun 17.

PMID:
19539796
5.

Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.

Hiremath GS, Cettomai D, Baynes M, Ratchford JN, Newsome S, Harrison D, Kerr D, Greenberg BM, Calabresi PA.

Mult Scler. 2009 Jun;15(6):735-40. doi: 10.1177/1352458509102844. Epub 2009 Apr 21.

PMID:
19383644
6.

Self-prescribed high-dose vitamin D3: effects on biochemical parameters in two men.

Kimball S, Vieth R.

Ann Clin Biochem. 2008 Jan;45(Pt 1):106-10. doi: 10.1258/acb.2007.007074.

7.

Presence of impaired intestinal calcium absorption in chronic hypovitaminosis D and its change after cholecalciferol supplementation: assessment by the calcium load test.

Gupta A, Gupta N, Singh N, Goswami R.

J Hum Nutr Diet. 2010 Feb;23(1):54-60. doi: 10.1111/j.1365-277X.2009.01003.x. Epub 2009 Oct 15.

PMID:
19843202
8.

Maintenance of wintertime vitamin D status with cholecalciferol supplementation is not associated with alterations in serum cytokine concentrations among apparently healthy younger or older adults.

Barnes MS, Horigan G, Cashman KD, Hill TR, Forsythe LK, Lucey AJ, McSorley EM, Kiely M, Bonham MP, Magee PJ, Strain JJ, Wallace JM.

J Nutr. 2011 Mar;141(3):476-81. doi: 10.3945/jn.110.131516. Epub 2011 Jan 26.

9.

Efficacy and safety of oral continuous low-dose versus short-term high-dose vitamin D: a prospective randomised trial conducted in a clinical setting.

Hackman KL, Gagnon C, Briscoe RK, Lam S, Anpalahan M, Ebeling PR.

Med J Aust. 2010 Jun 21;192(12):686-9.

PMID:
20565345
10.

Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.

Giusti A, Barone A, Pioli G, Girasole G, Razzano M, Pizzonia M, Pedrazzoni M, Palummeri E, Bianchi G.

J Am Geriatr Soc. 2010 Aug;58(8):1489-95. doi: 10.1111/j.1532-5415.2010.02970.x. Epub 2010 Jul 14.

PMID:
20646099
11.

Effect of vitamin D3 administration on serum 25-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3 and osteocalcin in vitamin D-deficient elderly people.

Guillemant S, Guillemant J, Feteanu D, Sebag-Lanoé R.

J Steroid Biochem. 1989 Dec;33(6):1155-9.

PMID:
2559250
12.

Long-term effects of giving nursing home residents bread fortified with 125 microg (5000 IU) vitamin D(3) per daily serving.

Mocanu V, Stitt PA, Costan AR, Voroniuc O, Zbranca E, Luca V, Vieth R.

Am J Clin Nutr. 2009 Apr;89(4):1132-7. doi: 10.3945/ajcn.2008.26890. Epub 2009 Feb 25.

13.

A positive dose-response effect of vitamin D supplementation on site-specific bone mineral augmentation in adolescent girls: a double-blinded randomized placebo-controlled 1-year intervention.

Viljakainen HT, Natri AM, Kärkkäinen M, Huttunen MM, Palssa A, Jakobsen J, Cashman KD, Mølgaard C, Lamberg-Allardt C.

J Bone Miner Res. 2006 Jun;21(6):836-44.

14.
15.

Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.

Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ.

J Bone Miner Res. 2004 Aug;19(8):1221-30. Epub 2004 May 24.

16.

Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency.

Isidro ML, Ruano B.

Endocrine. 2009 Oct;36(2):305-10. doi: 10.1007/s12020-009-9211-1. Epub 2009 Jul 14.

PMID:
19598008
17.

Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis.

Kimball S, Vieth R, Dosch HM, Bar-Or A, Cheung R, Gagne D, O'Connor P, D'Souza C, Ursell M, Burton JM.

J Clin Endocrinol Metab. 2011 Sep;96(9):2826-34. doi: 10.1210/jc.2011-0325. Epub 2011 Jun 22.

18.

Effect of oral cholecalciferol supplementation at physiological and supraphysiological doses in naturally vitamin D3-deficient subterranean damara mole rats (Cryptomys damarensis).

Buffenstein R, Skinner DC, Yahav S, Moodley GP, Cavaleros M, Zachen D, Ross FP, Pettifor JM.

J Endocrinol. 1991 Nov;131(2):197-202.

PMID:
1660517
19.

Supranutritional oral supplementation with vitamin D3 and calcium and the effects on beef tenderness.

Scanga JA, Belk KE, Tatum JD, Smith GC.

J Anim Sci. 2001 Apr;79(4):912-8.

20.

Estimation of the dietary requirement for vitamin D in free-living adults >=64 y of age.

Cashman KD, Wallace JM, Horigan G, Hill TR, Barnes MS, Lucey AJ, Bonham MP, Taylor N, Duffy EM, Seamans K, Muldowney S, Fitzgerald AP, Flynn A, Strain JJ, Kiely M.

Am J Clin Nutr. 2009 May;89(5):1366-74. doi: 10.3945/ajcn.2008.27334. Epub 2009 Mar 18.

Items per page

Supplemental Content

Write to the Help Desk